Hettich et al. reported that metformin decreased the hyperphosphorylation of TAU protein, BACE1 protein expression, and the production of Aβ peptides both in vivo and in vitro; thereafter metformin will be valuable for therapy against AD via interfering with both pathological hallmarks of AD [14]. This evidence concerns the gene BACE1 and Alzheimer disease.